Systemic inflammation and exercise tolerance in COPD Source: Annual Congress 2013 –Mechanisms contributing to exercise limitation in health and respiratory, cardiac and pulmonary vascular diseases Year: 2013
Exercise and inflammation in sarcoidosis Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010
Change in inflammation during COPD exacerbations Source: Eur Respir J 2005; 26: Suppl. 49, 15s Year: 2005
Exercise capacity in idiopathic pulmonary fibrosis and COPD Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010
Lung hyperinflation, dyspnoe, and exercise tolerance in patients with COPD exacerbation Source: Annual Congress 2010 - COPD exacerbation Year: 2010
Inflammation biomarkers of lung tissue damage in acute exacerbation of COPD patients Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013
Exercise hemodynamics in patients with COPD Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020
Pulmonary hypertension, and exercise tolerance in patients with COPD exacerbation Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects Year: 2010
Exercise and dyspnoea in COPD Source: Eur Respir Rev 2006; 15: 72-79 Year: 2006
Enhanced cytokine response to exercise in COPD Source: Annual Congress 2006 - COPD and systemic inflammation Year: 2006
Exercise testing in the evaluation of interventions Source: Annual Congress 2007 - PG12 - Cardiopulmonary exercise testing and interpretation Year: 2007
The inflammatory response to high doses of terbutaline during an acute exercise bout in patients with severe COPD Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013
Emphysema and the physiological response to incremental exercise in COPD Source: International Congress 2015 – Unravelling the mechanisms of symptoms and exercise limitationas in disease Year: 2015
Endothelial dysfunction and systemic inflammation during acute exacerbations of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016
Physiological responses to functional exercise capacity in interstitial lung disease patients with acute exacerbations Source: International Congress 2015 – Effects of rehabilitation, exercise, physical activity, hospitalisation and surgery on different conditions Year: 2015
Exercise tolerance and symptoms after standard rrehabilitation in emphysema-like COPD patients Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD Year: 2011
Exercise capacity and lobar hyperinflation in patients with COPD Source: Annual Congress 2013 –The latest insights in exercise testing and physical inactivity Year: 2013